HLA Demographics Study in Adults With Type 1 Diabetes

NCT06860516 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2026-05-06

No results posted yet for this study

Summary

This is a study to evaluate the HLA-DRB1\*04:01 genotype in adults that have been diagnosed with type 1 diabetes

Conditions

  • Diabetes Mellitus, Type I

Interventions

OTHER

blood draw or cheek swab

a blood draw or cheek swab for testing of HLA-DRB1\*04:01

Sponsors & Collaborators

  • GentiBio, Inc

    lead INDUSTRY

Principal Investigators

  • Mark Bach, MD · GentiBio, Inc

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-06-06
Primary Completion
2027-01-30
Completion
2027-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06860516 on ClinicalTrials.gov